Erik B. Nelson, MD

University of Cincinnati Academic Health Center, Cincinnati, Ohio

  • 11Articles
  • 37KReads
  • 1997–2025Active
  • 47Collaborators
  • 107Citations

About

Erik B. Nelson, MD, is affiliated with the University of Cincinnati Academic Health Center in Cincinnati, Ohio. He has contributed 11 articles to Psychiatrist.com between 1997 and 2025, focusing on topics such as sexual dysfunction, eating disorders, addiction, depression, mood disorders, and weight. Frequent co-authors include Paul E. Keck, Jr., Susan L. McElroy, Jeffrey A. Welge, James I. Hudson, and Renu Kotwal.

Publications

JCP
Effect of Aripiprazole or rTMS Augmentation Versus Switching to Venlafaxine on Quality of Life
Original Research

Effect of Aripiprazole or rTMS Augmentation Versus Switching to Venlafaxine on Quality of Life

August 11, 2025

Augmentation with aripiprazole, but not rTMS, improved quality of life significantly versus venlafaxine XR/duloxetine switch in patients with treatment-resistant depression.
, , , et al
JCP
Original Research

Olanzapine in the Treatment of Pathological Gambling: A Negative Randomized Placebo-Controlled Trial

March 14, 2008

, , , et al
JCP
Original Research

Atomoxetine in the Treatment of Binge-Eating Disorder: A Randomized Placebo-Controlled Trial

March 15, 2007

, , , et al
JCP
Original Research

Zonisamide in the Treatment of Binge Eating Disorder With Obesity: A Randomized Controlled Trial

December 15, 2006

, , , et al
JCP
Original Research

Are Mood Disorders and Obesity Related? A Review for the Mental Health Professional

May 1, 2004

, , , et al
JCP
Original Research

Psychiatric and Legal Features of 113 Men Convicted of Sexual Offenses

March 1, 2004

, , , et al
JCP
Original Research

Zonisamide in the Treatment of Binge-Eating Disorder: An Open-Label, Prospective Trial

January 1, 2004

, , , et al
JCP
Original Research

Citalopram in the Treatment of Binge-Eating Disorder: A Placebo-Controlled Trial

July 15, 2003

, , , et al
JCP
Original Research

A Placebo-Controlled, Crossover Trial of Granisetron in SRI-Induced Sexual Dysfunction

June 1, 2001

, , , et al
JCP
Article

Psychiatric Features of 36 Men Convicted of Sexual Offenses

June 30, 1999

, , , et al
JCP
Letter to the Editor

Resolution of Fluoxetine-Induced Sexual Dysfunction With the 5-HT3 Antagonist Granisetron

November 15, 1997

, ,

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe